HC Wainwright & Co. Reiterates Buy on VYNE Therapeutics – 1-for-18 Reverse Stock Split
HC Wainwright & Co. analyst Joseph Pantginis reiterates VYNE Therapeutics (NASDAQ:VYNE) with a Buy, 1-for-18 reverse stock split.
VYNE Therapeutics Announces 1-For-18 Reverse Stock Split
VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company"), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday.
The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P 500 also rose, gaining, 0.55% to 3,913.66.
Why Penny Stock VYNE Therapeutics Is Skyrocketing Today?
VYNE Therapeutics Inc (NASDAQ:VYNE) announced that the first vitiligo patient had been dosed in a Phase 1a/b trial of VYN201, a…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Prenetics Global (NASDAQ:PRE) stock rose 74.7% to $3.25 during Tuesday’s pre-market session. The market value of their…
Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket
Gainers
VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers
Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.